Elevated international normalized ratio from vitamin K supplement discontinuation

Annals of Pharmacotherapy

Volumn 45, Issue 1, 2011, Pages

  Miesner, Andrew R ^a   Sullivan, Timothy S ^b  

^a Department of Pharmaceutical Sciences   (United States)

^b Outcomes Pharmaceutical Health Care   (United States)

Author keywords

Discontinuation; Medication error; Phytonadione; Vitamin K supplementation; Warfarin

Indexed keywords

PHYTOMENADIONE; VITAMIN K GROUP; WARFARIN;

ADULT; ANTICOAGULANT THERAPY; ARTICLE; CASE REPORT; DRUG DOSE INCREASE; DRUG DOSE REDUCTION; DRUG SENSITIVITY; FOOD INTAKE; HEART ATRIUM FIBRILLATION; HUMAN; INTERNATIONAL NORMALIZED RATIO; LOW DRUG DOSE; MALE; PRIORITY JOURNAL; STROKE; VITAMIN SUPPLEMENTATION;

ANTICOAGULANTS; ATRIAL FIBRILLATION; DIETARY SUPPLEMENTS; DRUG INTERACTIONS; DRUG MONITORING; HEMORRHAGE; HUMANS; INTERNATIONAL NORMALIZED RATIO; MALE; MEDICATION ADHERENCE; MIDDLE AGED; RISK FACTORS; STROKE; VITAMIN K; WARFARIN;

EID: 78751489046     PISSN: 10600280     EISSN: None     Source Type: Journal    
DOI: 10.1345/aph.1P461     Document Type: Article

References (14)

1. Ansell J, Hirsh J, Hylek E, et al. Pharmacology and management of the vitamin K antagonists: American College of Chest Physicians evidencebased clinical practice guidelines (8th edition). Chest 2008;133:160S-98S. DOI 10.1378/chest.08-0670 (Pubitemid 351892967)
2. Fihn SD, McDonell M, Martin D, et al. Risk factors for complications of chronic anticoagulation: a multi-centre study. Ann Intern Med 1993;118: 511-20.
3. Reese AM, Farnett LE, Lyons R, et al. Low-dose vitamin K to augment anticoagulation control. Pharmacotherapy 2005;25:1746-51. DOI 10.1592/phco.2005.25.12.1746 (Pubitemid 41790098)
4. Ford SK, Misita CP, Shilliday BB, et al. Prospective study of supplemental vitamin K therapy in patients on oral anticoagulants with unstable international normalized ratios. J Thromb Thrombolysis 2007;24:23-7. DOI 10.1007/s11239-007-0014-z (Pubitemid 46831560)
5. Sconce E, Avery P, Wynne H, et al. Vitamin K supplementation can improve stability of anticoagulation for patients with unexplained variability in response to warfarin. Blood 2007;109:2419-23. DOI 10.1182/blood-2006-09-049262 (Pubitemid 46425883)
6. Rombouts EK, Rosendaal FR, Van Der Meer FJ. Daily vitamin K supplementation improves anticoagulant stability. J Thromb Haemost 2007; 5:2043-8. DOI 10.1111/j.1538-7836.2007.02715.x (Pubitemid 47450022)
7. Naranjo CA, Busto U, Sellers EM, et al. A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther 1981;30:239-45. (Pubitemid 12149145)
8. Boockvar K, Fishman E, Kyriacou CK, et al. Adverse events due to discontinuations in drug use and dose changes in patients transferred between acute and long-term care facilities. Arch Intern Med 2004;164: 545-50. DOI 10.1001/archinte.164.5.545 (Pubitemid 38314451)
9. Zhan C, Smith SR, Keyes MA, et al. How useful are voluntary medication error reports? The case of warfarin-related medication errors. Jt Comm J Qual Patient Saf 2008;34:36-45.
10. National Coordinating Council for Medication Error Reporting and Prevention. MCC MERP-about medication errors. www.nccmerp.org/ aboutMedErrors.html (accessed 2010 Sept 13).
11. National Coordinating Council for Medication Error Reporting and Prevention. NCC MERP taxonomy of medication errors. www.nccmerp.org/pdf/ taxo2001-07-31.pdf (accessed 2010 Sept 13).
12. Kurnik D, Lubetsky A, Lobestein R, et al. Multivitamin supplements may affect warfarin anticoagulation in susceptible patients. Ann Pharmacother 2003;37:1603-6. DOI 10.1345/aph.1D102 (Pubitemid 37315098)
13. Haines ST, Zeolla M, Witt DM. Venous thromboembolism. In: DiPiro JT, Talbert RL, Yee GC, et al., eds. Pharmacotherapy: a pathophysiologic approach. 6th ed. New York: McGraw-Hill, 2005:373-413.
14. The Joint Commission. Accreditation program: ambulatory health care. National patient safety goals. Effective July 1, 2010. www.jointcommission.org/ NR/rdonlyres/CB66FD84-B071-4AEA-8EF4-FD00AC050470/0/July2010NPSGs-Scoring-AHC2. pdf (accessed 2010 May 19).